Taletrectinib

About

Therapy type: Targeted therapy

Therapy strategy: NTRK inhibition, ROS1 inhibition

Mappings

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy.

Organization(s) Biomarker(s) Cancer type Therapy(ies)
FDA (1) v::ROS1 Non-Small Cell Lung Cancer Taletrectinib